Raquel F Gerlach Selected Research

lercanidipine

1/2011	Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension.
12/2008	Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats.
9/2008	Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
1/2006	Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raquel F Gerlach Research Topics

Disease

25	Hypertension (High Blood Pressure) 01/2021 - 01/2006
11	Vascular Remodeling 01/2021 - 06/2008
11	Cardiovascular Diseases (Cardiovascular Disease) 02/2016 - 12/2008
10	Pulmonary Embolism 12/2013 - 07/2005
8	Hypertrophy 12/2015 - 09/2008
8	Renovascular Hypertension (Goldblatt Syndrome) 12/2015 - 05/2009
7	Inflammation (Inflammations) 01/2021 - 08/2007
6	Pulmonary Hypertension 12/2013 - 07/2005
5	Cardiomegaly (Heart Hypertrophy) 01/2018 - 02/2013
4	Fibrosis (Cirrhosis) 10/2015 - 02/2013
4	Periodontal Diseases (Periodontal Disease) 04/2015 - 04/2009
4	Chronic Periodontitis 04/2015 - 02/2010
4	Thrombosis (Thrombus) 12/2013 - 11/2009
3	Abdominal Aortic Aneurysm 07/2015 - 02/2011
2	COVID-19 01/2022 - 12/2021
2	Atherosclerosis 10/2015 - 08/2007
2	Aneurysm (Aneurysms) 03/2015 - 02/2011
2	Hypotension (Low Blood Pressure) 07/2009 - 09/2005
2	Multiple Sclerosis 09/2006 - 02/2006
1	Hypercholesterolemia 02/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Pain (Aches) 01/2021
1	Facial Pain (Myofacial Pain) 01/2021
1	Metabolic Bone Diseases (Osteopenia) 10/2019
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2014
1	Right Ventricular Dysfunction 12/2013
1	Hyperplasia 08/2013

Drug/Important Bio-Agent (IBA)

49	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 09/2005
13	AntioxidantsIBA 01/2019 - 01/2006
12	Doxycycline (Periostat)FDA LinkGeneric 10/2019 - 09/2005
10	Matrix Metalloproteinase 9 (Gelatinase B)IBA 02/2011 - 09/2005
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 05/2009
7	NitritesIBA 01/2019 - 07/2009
7	salicylhydroxamic acid (SHAM)IBA 10/2015 - 06/2008
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2011
6	CollagenIBA 10/2015 - 05/2012
5	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 09/2008
5	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2015 - 11/2005
5	Matrix Metalloproteinase InhibitorsIBA 01/2014 - 02/2011
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 03/2012
4	Sildenafil Citrate (Viagra)FDA Link 12/2015 - 07/2005
4	Eosine Yellowish-(YS) (Eosin)IBA 10/2015 - 02/2013
4	Tissue Inhibitor of Metalloproteinase-1IBA 08/2011 - 07/2006
4	Tissue Inhibitor of Metalloproteinase-2IBA 08/2011 - 10/2009
4	Metalloproteases (Metalloproteinases)IBA 02/2011 - 06/2008
4	lercanidipineIBA 01/2011 - 01/2006
3	Atorvastatin (Lipitor)FDA Link 12/2015 - 01/2007
3	C.I. direct red 80IBA 10/2015 - 02/2013
3	Hematoxylin (Haematoxylon)IBA 08/2014 - 02/2013
3	APTIBA 12/2013 - 11/2009
3	Peroxidase (Myeloperoxidase)IBA 06/2013 - 02/2010
3	tempolIBA 04/2013 - 05/2009
2	CholesterolIBA 02/2022 - 10/2015
2	EnzymesIBA 01/2022 - 10/2014
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 02/2006
2	GelatinasesIBA 01/2021 - 10/2015
2	Pharmaceutical PreparationsIBA 10/2019 - 05/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2016 - 06/2011
2	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2015 - 02/2013
2	Nebivolol FDA Link 08/2014 - 12/2013
2	3-nitrotyrosineIBA 08/2014 - 12/2013
2	Metoprolol (Toprol-XL)FDA LinkGeneric 08/2014 - 12/2013
2	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2013 - 05/2012
2	ElastinIBA 08/2013 - 05/2012
2	Troponin IIBA 07/2012 - 02/2011
2	Interleukin-6 (Interleukin 6)IBA 05/2011 - 04/2009
2	Biological ProductsIBA 05/2011 - 10/2009
2	SelectinsIBA 04/2009 - 08/2007
2	C-Reactive ProteinIBA 04/2009 - 08/2007
1	HLA-G Antigens (HLA G)IBA 01/2022
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 12/2021
1	Peptide Receptors (Peptide Receptor)IBA 01/2021
1	Angiotensin IIIBA 10/2015
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2015
1	ApolipoproteinsIBA 10/2015
1	NF-kappa B (NF-kB)IBA 10/2015
1	prolinedithiocarbamate (PDTC)IBA 10/2015
1	pyrrolidine dithiocarbamic acidIBA 10/2015
1	OzoneIBA 04/2015
1	Superoxides (Superoxide)IBA 12/2013
1	Dobutamine FDA LinkGeneric 12/2013
1	Thiobarbituric Acid Reactive SubstancesIBA 12/2013
1	Interleukin-4 (Interleukin 4)IBA 12/2013
1	aliskiren FDA Link 08/2013
1	Losartan (Cozaar)FDA LinkGeneric 08/2013
1	Mitogen-Activated Protein Kinase 3IBA 08/2013
1	Renin InhibitorsIBA 08/2013
1	Enalapril FDA LinkGeneric 12/2012
1	Interleukin-8 (Interleukin 8)IBA 10/2012
1	Calcimycin (A23187)IBA 03/2012
1	TetracyclinesIBA 03/2012
1	EndopeptidasesIBA 12/2011
1	ZincIBA 12/2011
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2011

Therapy/Procedure

13	Surgical Instruments (Clip) 01/2018 - 06/2008
10	Therapeutics 01/2021 - 04/2009
3	Microspheres (Microsphere) 11/2009 - 09/2005
1	Ovariectomy (Oophorectomy) 10/2019
1	Aftercare (After-Treatment) 08/2014
1	Ligation 05/2011